|Ms. Dan Zheng||Director Gen. & Vice Chairman||N/A||N/A||1965|
|Mr. Wu Jun Lan||Deputy GM, CFO, Board Sec. & Director||N/A||N/A||1975|
|Mr. Rui Qiang Chen||Gen. Mang. of Human Resource Center and Deputy Gen. Mang.||N/A||N/A||1977|
|Mr. Kun Zhang||Deputy Gen. Mang.||N/A||N/A||1976|
|Mr. Kai Dong||Deputy Gen. Mang.||N/A||N/A||1974|
|Mr. Guo Wei Gao||Deputy Gen. Mang.||N/A||N/A||1973|
|Mr. Xiao Lun Qian||Deputy Gen. Mang.||N/A||N/A||1962|
|Mr. Qin Pan||Deputy Gen. Mang.||N/A||N/A||N/A|
|Mr. Long Wang||Deputy Gen. Mang.||N/A||N/A||1964|
Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research, development, production, and marketing of various pharmaceutical products in China. The company offers Chinese herb preparation products, medicinal granules, synthetic drugs, biotech drugs, medical apparatus, and Internet based therapy. It is also involved in the research and development of various drugs in the areas of sepsis, pulmonary hypertension, leukemia, cardiovascular and cerebrovascular diseases, arthritis, ischemic stroke, HCV, vascular disease, psychosis, and chemotherapy, as well as anesthesia drugs and immunomodulators. The company was founded in 1996 and is based in Tianjin, China.
Tianjin Chase Sun Pharmaceutical Co.,Ltds ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.